...
首页> 外文期刊>Technology in cancer research & treatment. >Boron neutron capture therapy for glioblastoma: is it worth pursuing?
【24h】

Boron neutron capture therapy for glioblastoma: is it worth pursuing?

机译:胶质母细胞瘤的硼中子捕获疗法:值得追求吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Presently glioblastomas are incurable brain tumors. The prospect of treating this deadly disease has been the major justification for the current programs of boron neutron capture therapy (BNCT) throughout the world. However, based on pharmacological and cell biological considerations, it is improbable that BNCT will ever be an effective therapy for this tumor. Indeed, a review of the published literature over the last 50 years fails to provide justification for developing BNCT past its present experimental stage.
机译:目前,胶质母细胞瘤是无法治愈的脑肿瘤。治疗这种致命疾病的前景已成为当前全球硼中子俘获治疗(BNCT)计划的主要理由。然而,基于药理学和细胞生物学的考虑,BNCT永远不可能成为对该肿瘤的有效疗法。实际上,对过去50年中已发表文献的回顾并不能为在目前的实验阶段发展BNCT提供合理的依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号